An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

In the new study, published March 11 in Science Translational Medicine, the researchers linked DP cells to shorter survival times in patients with advanced breast cancer, especially the aggressive ...

Breast cancer remains the most common invasive cancer diagnosed in women in the United States, accounting for about one in three new female cancers each year. This equates to an expected 310,720 new ...

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

It's *** lesser known breast cancer that develops in *** patient's milk producing glands, and cases of lobular breast cancer are on the rise in the US. Most people aren't familiar with this subtype, ...

A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...